| Trial registration number
|
NCT04864925 |
Full text link
Last imported at : April 30, 2021, 7:54 a.m.
Source : ClinicalTrials.gov
|
https://clinicaltrials.gov/show/NCT04864925
|
First author
Last imported at : April 30, 2021, 7:54 a.m.
Source : ClinicalTrials.gov
|
Not reported
|
Contact
Last imported at : April 30, 2021, 7:54 a.m.
Source : ClinicalTrials.gov
|
Not reported
|
Registration date
Last imported at : April 30, 2021, 7:54 a.m.
Source : ClinicalTrials.gov
|
2021-04-29
|
Recruitment status
Last imported at : Jan. 20, 2022, 11:30 a.m.
Source : ClinicalTrials.gov
|
Completed
|
Study design
Last imported at : April 30, 2021, 7:54 a.m.
Source : ClinicalTrials.gov
|
RCT
|
Allocation
Last imported at : April 30, 2021, 7:54 a.m.
Source : ClinicalTrials.gov
|
Randomized
|
Design
Last imported at : April 30, 2021, 7:54 a.m.
Source : ClinicalTrials.gov
|
Parallel
|
Masking
Last imported at : April 30, 2021, 7:54 a.m.
Source : ClinicalTrials.gov
|
Blind label
|
Center
Last imported at : March 15, 2023, 4 a.m.
Source : ClinicalTrials.gov
|
single-center
|
Study aim
Last imported at : April 30, 2021, 7:54 a.m.
Source : ClinicalTrials.gov
|
Treatment
|
Inclusion criteria
Last imported at : April 30, 2021, 7:54 a.m.
Source : ClinicalTrials.gov
|
inclusion criteria:
- enrolled subjects between the ages of 18-64 and have tested positive for covid19.
|
Exclusion criteria
Last imported at : April 30, 2021, 7:54 a.m.
Source : ClinicalTrials.gov
|
-
|
Number of arms
Last imported at : April 30, 2021, 7:54 a.m.
Source : ClinicalTrials.gov
|
2
|
Funding
Last imported at : April 30, 2021, 7:54 a.m.
Source : ClinicalTrials.gov
|
Colgate Palmolive
|
Inclusion age min
Last imported at : April 30, 2021, 7:54 a.m.
Source : ClinicalTrials.gov
|
18
|
Inclusion age max
Last imported at : April 30, 2021, 7:54 a.m.
Source : ClinicalTrials.gov
|
64
|
Countries
Last imported at : April 30, 2021, 7:54 a.m.
Source : ClinicalTrials.gov
|
United States
|
Type of patients
Last imported at : April 30, 2021, 7:54 a.m.
Source : ClinicalTrials.gov
|
No restriction on type of patients
|
Severity scale
Last imported at : April 30, 2021, 7:54 a.m.
Source : ClinicalTrials.gov
|
0: No restriction on type of patients
|
Total sample size
Last imported at : Jan. 20, 2022, 11:30 a.m.
Source : ClinicalTrials.gov
|
46
|
primary outcome
Last imported at : April 30, 2021, 7:54 a.m.
Source : ClinicalTrials.gov
|
Primary outcome based on reductions of viral titers in the oral cavity as determined by qRT-PCR;Primary outcome based on reductions of viral titers in the oral cavity as determined by qRT-PCR;Primary outcome based on reductions of viral titers in the oral cavity as determined by qRT-PCR
|
Notes
Last imported at : April 30, 2021, 7:54 a.m.
Source : ClinicalTrials.gov
|
None
|
Phase
Last imported at : April 30, 2021, 7:54 a.m.
Source : ClinicalTrials.gov
|
Phase 3
|
Arms
Last imported at : April 30, 2021, 7:54 a.m.
Source : ClinicalTrials.gov
|
[{"arm_notes": "", "treatment_id": 1301, "treatment_name": "Toothpaste", "treatment_type": "Mouthwash", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}]
|